Login
$AMBQ
$44.03 +$0.00 (0.0%) After hours

$AMBQ SEC Filings

Filed On Filing
16 Nov 2026 Form 4: Esaka Fumihide, Director

Received 50,000 shares by exercise or conversion ($630K) · Sold 50,000 shares ($2.49M) · Received 54,821 shares by exercise or conversion ($691K) · 3 more

16 Nov 2026 144
16 Nov 2026 144
13 Nov 2026 144
12 Nov 2026 144
10 Nov 2026 10-Q
10 Nov 2026 8-K: Results of Operations and Financial Condition

Third quarter net sales increased 110% year-over-year on broad demand across customers, product families and form factors

27 Oct 2026 SCHEDULE 13G/A
16 Oct 2026 Form 4: Hanson Scott McLean, Director

Received 7,000 shares by exercise or conversion ($56.8K) · Sold 7,000 shares ($357K)

16 Oct 2026 Form 4: Esaka Fumihide, Director

Received 5,000 shares by exercise or conversion ($40.6K) · Sold 5,000 shares ($255K)

16 Oct 2026 Form 4: Chen Sean Chihhsiang, President and COO

Received 15,000 shares by exercise or conversion ($122K) · Sold 15,000 shares ($772K)

06 Oct 2026 Form 4: Winzeler Jeffrey G, Chief Financial Officer

Sold 5,455 shares ($380K)

06 Oct 2026 Form 4: Esaka Fumihide, Director

Sold 16,560 shares ($1.15M)

06 Oct 2026 Form 4: Hanson Scott McLean, Director

Sold 8,680 shares ($604K)

06 Oct 2026 Form 4: Chen Sean Chihhsiang, President and COO

Sold 5,802 shares ($404K) · Sold 8,205 shares ($548K)

05 Oct 2026 144
02 Oct 2026 144
02 Oct 2026 144
02 Oct 2026 144
02 Oct 2026 144

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support